Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.
In a large study published in Alimentary Pharmacology and Therapeutics, researchers at 19 centers in the UK report that, among 2,385 patients with inflammatory bowel disease, 14.8% showed evidence of steroid excess or dependency, and the steroid excess was judged avoidable in over 50% of cases.
The seven centers that had participated in a quality improvement program had significantly fewer patients (11.5% versus 17.1%) receiving excess steroids.
Looking at steroid prescribing for inflammatory bowel disease and trying to reduce steroid excess can be a powerful way to improve patient care and outcomes."
Christian P. Selinger, MD, MSc, MRCP, lead author from St. James University Hospital
Source:
Journal reference:
Selinger, C.P., et al. (2019) Assessment of steroid use as a key performance indicator in inflammatory bowel disease—analysis of data from 2385 UK patients. Alimentary Pharmacology and Therapeutics. doi.org/10.1111/apt.15497.
Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases